In Figure 1C on page 479 in the 11 February 2020 issue, the x-axis label “2” should read “7.” The corrected figure panel is shown below. The error has been corrected in the published article.
© 2020 by The American Society of Hematology
2020
Advertisement
Carden MA, Gaddh M, Hoskote A, et al. Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood Adv. 2020;4(3):477-481.. Blood Adv 2020; 4 (6): 1093. doi: https://doi.org/10.1182/bloodadvances.2020001818
Download citation file:
In Figure 1C on page 479 in the 11 February 2020 issue, the x-axis label “2” should read “7.” The corrected figure panel is shown below. The error has been corrected in the published article.
Advertisement
Advertisement
Advertisement
Advertisement